Viewing Study NCT05993832


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2026-01-01 @ 7:28 PM
Study NCT ID: NCT05993832
Status: RECRUITING
Last Update Posted: 2023-08-28
First Post: 2023-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures
Sponsor: Boston University Charles River Campus
Organization:

Study Overview

Official Title: Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures
Status: RECRUITING
Status Verified Date: 2023-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Mutual exclusivity is a word learning constraint in which the learner assumes that a given word refers to only one category of objects. In spoken languages, mutual exclusivity has been demonstrated in monolingual children as young as 17 months and cross-linguistically, while multilingual learners show an attenuated mutual exclusivity bias. Mutual exclusivity has not been robustly demonstrated in deaf children acquiring American Sign Language (ASL). Further, it is unclear if mutual exclusivity applies to those learning both a signed and a spoken language. Like unimodal bilinguals, bimodal bilingual (BiBi) children learn two words for an object, but these words are separated by modality. A BiBi child could therefore assume that all objects have two words (like unimodal bilinguals) or that all objects have one spoken word and one sign (within-modality mutual exclusivity). The goals of the current study are to demonstrate mutual exclusivity in monolingual deaf children acquiring ASL, and to determine if BiBi deaf children utilize mutual exclusivity within each modality.
Detailed Description: The investigators will investigate how deaf children prioritize input cues to word meaning when linguistic cues (i.e. mutual exclusivity) and referential gaze are in conflict in a structured word learning task.

Participants: Deaf children (n=40) ages 24-60 months. Investigators will recruit 60 children to allow for 33% attrition. While the inclusion criteria are the same as other studies, here investigators do use spoken language exposure as a grouping variable, as follows: based on responses to the language background questionnaire regarding exposure to spoken English, participants will be grouped according to language use as monolingual ASL or bimodal bilingual (spoken English/ASL). Participants will be identified as bimodal bilingual is 1) the primary caregiver reports spoken English to communicate with their child (either alone or in conjunction with ASL), and 2) the primary caregiver reports that their child's ability to understand spoken English is at least a 3 on a Likert-type scale ranging from 0-5. Parents in this group will complete the short-form English CDI in addition to the ASL language measures.

Procedure: Participants will sit across a table from an experimenter who will present pairs of objects--one familiar, one novel--with one pair in each of nine trials (three per condition). The experimenter will prompt the participant to give them one of the toys, signing "I WANT YOU-GIVE-ME WHAT?" Then the experimenter will provide a cue; the child's selection will be recorded. In the gaze condition, the cue will be a gaze shift to the familiar object. In the mutual exclusivity condition, the cue will be a novel sign. In the conflict condition, both a gaze shift to the familiar object and a novel sign will be used. The trial order and object pair will be pseudo-randomly assigned.

Planned analysis: Investigators will use an omnibus mixed effects binomial model to determine how well condition and language environment predict the likelihood to select the novel object, with item and child as random factors.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: